NUVBHealthcareSmall-Cap

Nuvation Bio Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Nuvation Bio Inc. (NUVB), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are NUVB insiders buying or selling?

Nuvation Bio Inc. insiders reported 19 open-market buys ($32.2M) and 21 sells ($73.5M) across 40 Form 4 filings — a net selling position of $41.2M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jun 24, 2026)

Total Form 4 filings
40
SEC EDGAR
Insider filers
17
Insider buys (19)
$32.2M
Insider sells (21)
$73.5M

Insider sentiment

Net selling

Net insider flow of $41.2M in net selling. 1 insider buy in the last 90 days.

Recent NUVB insider transactions

DateInsiderRoleTypeSharesPriceValue
Jun 24, 2026Stacy MarkelCHIEF PEOPLE OFFICERSale125.0K$6.03$753.2K
Jun 24, 2026Kerry WentworthCHIEF REGULATORY OFFICERSale63.0K$6.02$379.2K
Jun 24, 2026Philippe SauvageChief Financial OfficerSale47.7K$6.01$286.4K
Jun 12, 2026Robert MashalDirectorPurchase25.0K$4.73$118.3K
Apr 21, 2026Kerry WentworthCHIEF REGULATORY OFFICERSale36.8K$5.01$184.3K
Apr 21, 2026Dongfang LiuCHIEF MEDICAL OFFICERSale50.0K$5.02$251.0K
Apr 8, 2026Kerry WentworthCHIEF REGULATORY OFFICERSale200.0K$4.52$903.6K
Dec 3, 2025Dongfang LiuCHIEF MEDICAL OFFICERSale150.0K$7.82$1.2M
Nov 26, 2025Dongfang LiuCHIEF MEDICAL OFFICERSale20.0K$7.75$155.0K
Nov 24, 2025Gary HattersleyCHIEF SCIENTIFIC OFFICERSale369.1K$7.23$2.7M
Nov 24, 2025Dongfang LiuCHIEF MEDICAL OFFICERSale20.0K$7.00$140.1K
Nov 21, 2025David C. HanleyCHIEF TECHNICAL OPERATIONSSale200.0K$7.14$1.4M
Nov 19, 2025Dongfang LiuCHIEF MEDICAL OFFICERSale30.0K$4.93$148.0K
Oct 29, 2025Gary HattersleyCHIEF SCIENTIFIC OFFICERSale100.0K$5.02$502.5K
Jun 18, 2025Stacy MarkelCHIEF PEOPLE OFFICERPurchase10.0K$1.71$17.1K
Jun 18, 2025Philippe SauvageChief Financial OfficerPurchase7.3K$1.81$13.2K
Jun 18, 2025Colleen SjogrenChief Commercial OfficerPurchase50.0K$1.81$90.3K
Jun 18, 2025Kerry WentworthCHIEF REGULATORY OFFICERPurchase50.0K$1.79$89.7K
Jun 18, 2025Hung DavidPRESIDENT AND CEOPurchase500.0K$1.79$893.5K
May 6, 2025Dongfang LiuCHIEF MEDICAL OFFICERSale20.0K$2.50$50.0K
Apr 9, 2025Hung DavidPRESIDENT AND CEOPurchase500.0K$1.64$820.2K
Apr 3, 2025Robert MashalDirectorPurchase100.0K$1.67$167.0K
Nov 13, 2024Junyuan Jerry WangCEO, ANHEART THERAPEUTICS LTD.Sale56.4K$2.89$162.9K
Oct 10, 2024Robert MashalDirectorPurchase100.0K$2.20$220.0K
Jun 26, 2024Xiangmin CuiDirectorPurchase277.9K$2.97$825.3K

Showing the 25 most recent of 40 Form 4 filings for Nuvation Bio Inc..

Most active NUVB insiders

  • Dongfang Liu6 filings
  • Omega Fund V, L.P.6 filings
  • Kerry Wentworth4 filings
  • Oleg Nodelman4 filings
  • Robert Mashal3 filings

Ask anything about NUVB insider activity

Use Trabud's AI agent to query Nuvation Bio Inc.'s Form 4 history in plain English — "Show me NUVB CEO purchases this year" or compare it against any other ticker.

Open the AI agent

NUVB insider trading FAQ

Are Nuvation Bio Inc. insiders buying or selling?

Across 40 SEC Form 4 filings, Nuvation Bio Inc. (NUVB) insiders reported 19 open-market purchases totaling $32.2M and 21 sales totaling $73.5M. That is a net selling position of $41.2M.

How many insiders trade NUVB stock?

17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Nuvation Bio Inc.. The most recent filing was accepted on Jun 24, 2026.

Where does Trabud get NUVB insider trading data?

All NUVB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content